Piyush Agarwal to Antineoplastic Agents
This is a "connection" page, showing publications Piyush Agarwal has written about Antineoplastic Agents.
Connection Strength
0.810
-
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics. Sci Rep. 2017 03 15; 7(1):201.
Score: 0.255
-
Managing noninvasive recurrences after definitive treatment for muscle-invasive bladder cancer or high-grade upper tract urothelial carcinoma. Curr Opin Urol. 2015 Sep; 25(5):468-75.
Score: 0.230
-
Emerging drugs for targeted therapy of bladder cancer. Expert Opin Emerg Drugs. 2007 Sep; 12(3):435-48.
Score: 0.132
-
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. Lancet Oncol. 2020 08; 21(8):1099-1109.
Score: 0.080
-
Targeted therapies in urothelial carcinoma. Curr Opin Oncol. 2014 May; 26(3):305-20.
Score: 0.052
-
Targeted therapies in bladder cancer--an update. Urol Oncol. 2007 Sep-Oct; 25(5):433-8.
Score: 0.033
-
Trimodality therapy in bladder cancer: who, what, and when? Urol Clin North Am. 2015 May; 42(2):169-80, vii.
Score: 0.014
-
Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer. 2014 May-Jun; 38(3):80-108.
Score: 0.013